DEA issues first federal registrations to Texas medical marijuana dispensaries

The U.S. Drug Enforcement Administration has begun issuing federal registrations to medical marijuana dispensaries in Texas. This marks the first step in moving state-approved cannabis businesses under direct federal oversight.

The Department of Justice announced the action on Oct. 30. The agency stated that the initial group of registered entities includes businesses in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia, and West Virginia. Over 900 businesses nationwide are part of this first wave of the new regulatory system.

These registrations implement an order signed by U.S. Attorney General Todd Blanche on April 23. The directive placed specific state-regulated medical marijuana products into Schedule III of the federal Controlled Substances Act. To qualify, each business had to successfully complete a DEA pre-registration investigation and meet other federal standards.

The DEA started with dispensaries that applied during the initial 60-day period outlined in the order. The agency will continue reviewing applications and issuing registrations in subsequent phases. A state license alone does not guarantee federal registration. Registered facilities must now comply with federal rules regarding security, recordkeeping, and inventory controls for controlled substances.

The order also affects the supply chain. The DOJ is currently reviewing applications from medical marijuana manufacturers and distributors. These businesses require additional scrutiny, including facility inspections and production quota determinations. Companies that applied early and are still pending may continue certain transactions with newly registered entities while following the order's requirements.

The federal action does not legalize recreational marijuana. Marijuana that falls outside the scope of the order remains classified as a Schedule I controlled substance. The agency has also created an expedited administrative hearing process to consider moving marijuana more broadly from Schedule I to Schedule III. FDA-approved products containing marijuana are now also classified as Schedule III.

The Department of Justice said it will keep evaluating applications as the implementation process moves forward. Businesses that meet the federal requirements will receive their official status, integrating them into the federal framework for regulated cannabis activities.